Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired ...

Teva Pharma (TEVA) stock gains as the company and Samsung Bioepis launch Epysqli, a biosimilar to AstraZeneca's (AZN) rare ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization ...

AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

The AstraZeneca PLC ADR AZN slid 7.39% to $68.46 Friday, on what proved to be an all-around poor trading session for the ...

FTSE shares moved lower on 3 April, after US President Donald Trump introduced hefty tariffs on its trading partners. These ...

AstraZeneca PLC closed 16.13% short of its 52-week high of £133.88, which the company reached on September 3rd.

Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a midstage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

Learn more about whether AstraZeneca PLC or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether AstraZeneca PLC or Corcept Therapeutics Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.